China State Council Lines Up Tasks In Five Key Healthcare Reforms
This article was originally published in PharmAsia News
China's General Office of the State Council recently released the tasks identified for five key healthcare reforms in 2009: speed up establishment of a basic medical care system; set up a national essential drug system; improve the grassroots medical care service system; promote uniformity in basic public healthcare; and push for reform pilots in public hospitals. According to the line-up of requirements, the national essential drug list is to be finalized by the end of November, with all drugs included in the drug catalog of the national basic medical insurance. Public hospital reform pilots will be conducted in about 100 hospitals of 12 prefecture cities identified from the Eastern, Central and Western regions of China. The State Council task force, which leads the deepening of the healthcare reform, will inspect the overall implementation by year end. (Click here for more - Chinese language)
You may also be interested in...
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.
In the age of coronavirus, human factors professionals are doing their best to find their way through the pandemic by putting unique twists on usability testing to see what works and what doesn’t in the new reality. That’s the topic of this week’s podcast.